Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Establishment Labs Holdings Inc (NQ: ESTA )

49.42 +0.42 (+0.86%)
Streaming Delayed Price Updated: 3:08 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Establishment Labs Holdings Inc

< Previous 1 2 3 4 Next >
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Amended Credit Facility with Oaktree
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Commercial Launch of Motiva Implants in China
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Third Quarter 2023 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces FDA Clearance of Motiva Flora SmoothSilk Tissue Expander
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Record Second Quarter 2023 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Participate in Two Upcoming Investor Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical Tools
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Record First Quarter 2023 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce First Quarter 2023 Financial Results on May 8
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Pricing of Public Offering of Common Shares
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Proposed Public Offering of Common Shares
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Begins a New Era in Breast Aesthetics with Launch of Mia Femtech in Japan
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Participation in The Aesthetic Meeting 2023
From Establishment Labs Holdings Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.